New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their... (l trials with patients with primary hype...)

New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition

Date:9/4/2007

l trials with patients with primary hypercholesterolemia, when WelChol was given alone in addition to a low-fat diet and exercise, it was shown to reduce LDL cholesterol by an average of 15% to 18%.

When WelChol is given in combination with a statin, the combination can lower cholesterol levels more effectively than using either therapy alone. In pivotal studies where WelChol was taken with a statin, WelChol 3.8 g provided up to an additional mean 16% (32 mg/dL) reduction in LDL cholesterol. WelChol is the only non-systemic cholesterol-lowering agent approved by the FDA for combination with a statin. WelChol can be used in combination with any dose of any statin.

WelChol is engineered for affinity and high capacity bile acid binding. It has been studied with four commonly prescribed statins - Lipitor(R) (atorvastatin calcium), Zocor(R) (simvastatin), Pravachol(R) (pravastatin sodium) and Mevacor(R) (lovastatin). Additionally, WelChol has been studied with fenofibrate and had no significant effect on the bioavailability of fenofibrate. Like most prescription drugs, WelChol has not been studied in combination with all medications or supplements. Patients should always tell their doctor about all medications and supplements they are taking before starting any new therapy, including WelChol.

WelChol is not for everyone, especially those with bowel blockage. Caution should be exercised when treating patients who have trouble swallowing or severe stomach or intestinal problems. Side effects may include constipation, indigestion and gas. WelChol, either alone or in combination with a statin or fenofibrate, has not been shown to prevent heart disease or heart attacks.

WelChol is only indicated for the reduction of LDL-C either alone or in combination with a statin in patients with primary hypercholesterolemia. Additionally, WelChol has demonstrated beneficial effects on other lipid parameters such as HDL-C and APO-B. WelChol has also been studied in
'/>"/>

1

GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. Trace Analysis Optimizing Sensitivity Finnigan Surveyor PDA Detector
2. Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard
3. Economic survey reveals better 2006 results
4. Survey company sells Wisconsin GIS piece
5. MoneyTree Survey reports no venture investment activity in Wisconin in Q2
6. Madison top-ranked In Digital Cities Survey
7. Student survey shows surging demand for wireless access
8. Galactic survey reveals a new look for the Milky Way
9. Two Wisconsin companies hold spots on Computerworld employee survey
10. Money Tree survey shows lull in Wisconsin venture capital deals
11. Survey of High Tech Company Leaders Points Out Need for Personal Growth

Post Your Comments:

New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their...(l trials with patients with primary hype...)